We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+22.82%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$701M
AUM Growth
+$121M
Cap. Flow
+$42.4M
Cap. Flow %
6.05%
Top 10 Hldgs %
81.47%
Holding
27
New
2
Increased
7
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
MZOR
Mazor Robotics Ltd.
MZOR
+$19.4M
2
HNSN
HANSEN MEDICAL, INC. COM NEW
HNSN
+$12.7M
3
THOR
THORATEC CORPORATION
THOR
+$11.6M
4
AXDX
Accelerate Diagnostics
AXDX
+$4.59M
5
TTHI
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
+$2.76M

Top Sells

Rank Stock Value
1
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
+$11.2M
2
THC icon
Tenet Healthcare
THC
+$1.04M
3
MNKD icon
MannKind Corp
MNKD
+$356K
4
ACOR
Acorda Therapeutics
ACOR
+$254K
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$12.6K

Sector Composition

Rank Sector Weight
1 Healthcare 66.33%
2 Consumer Staples 0.3%
3 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGEN icon
26
Precigen
PGEN
$2.33B
$284K 0.04%
+12,556
New +$290K
MNKD icon
27
MannKind Corp
MNKD
$1.22B
– –
-10,948
Closed -$356K
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q3 2013 Portfolio in Review

As of Q3 2013, Oracle Investment Management held 27 positions worth $701M, up 21% from $580M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Oracle Investment Management deployed $42.4M of net new capital in Q3 2013, opening 2 new positions and adding to 7 existing holdings. Its largest new stake was Biolase, Inc.: 47 shares worth $1.11M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 75% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Oncternal Therapeutics, Inc. Common Stock, an estimated $11.2M trimmed.

  • Oracle Investment Management's largest Q3 2013 buy was Biolase, Inc.: 47 shares worth $1.11M.
  • Oracle Investment Management added most to Mazor Robotics Ltd. in Q3 2013, an estimated $19.4M increase.
  • Oracle Investment Management's biggest Q3 2013 reduction was Oncternal Therapeutics, Inc. Common Stock, cutting an estimated $11.2M.
  • Oracle Investment Management fully exited MannKind Corp in Q3 2013, selling an estimated $356K.
  • Oracle Investment Management's ten largest holdings make up 81% of its $701M portfolio in Q3 2013.
  • Oracle Investment Management opened 2 new positions and closed 1 in Q3 2013.
  • Oracle Investment Management's portfolio value rose 21% quarter-over-quarter to $701M.

Based on Oracle Investment Management's 13F filing for Q3 2013, filed 14 Nov 2013.